Brand Intelligence Graph
Company Overview
About eMed
eMed is a GLP-1 and metabolic health benefits platform built specifically for employer-sponsored health plans, the fastest-growing category in US workplace benefits. The company raised $200 million in Series A financing in March 2026 at a $2 billion+ valuation led by AON Consulting, with backing from Linda Yaccarino (former Twitter/X CEO, now eMed CEO) and Tom Brady. Claiming 91%+ medication adherence rates, eMed positions itself as the most effective GLP-1 benefits program available to employers.
Business Model & Competitive Advantage
The platform's capitated pricing model shifts financial risk from employers to eMed — charging a fixed fee per member regardless of how many GLP-1 prescriptions are written — which makes total cost predictable for HR and benefits teams wrestling with runaway drug spend. GLP-1 medications (Ozempic, Wegovy) have become the most requested workplace health benefit in the US, and their list prices create budget pressure that employers urgently need managed.
Competitive Landscape 2025–2026
eMed combines clinical oversight (prescribers, pharmacists, registered dietitians) with behavioral coaching and medication management to improve outcomes and reduce GLP-1 discontinuation, which runs 50-70% in typical commercial populations. The company's approach is to treat GLP-1 therapy as a managed clinical program rather than a pharmacy benefit, driving the adherence rates it claims as a differentiator.
Key Differentiators
Strong Challenger
eMed is an established challenger with significant market presence and competitive offerings in Digital Health.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Noom
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to beha
Hims & Hers
Hims & Hers is a consumer telehealth and pharmacy platform founded in 2017 in San Francisco by Andrew Dudum, built on the mission of making high-quality healthcare affordable and stigma-free for condi
Doximity
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic
Headspace
Headspace is a mental wellness company founded in 2010 by Andy Puddicombe and Rich Pierson that has grown into one of the most widely used mindfulness and meditation apps globally. The platform offers
Persivia
Persivia is a unified AI healthcare platform spanning care management, population health analytics, and revenue cycle operations — one of the few integrated platforms that addresses both the clinical
Compare eMed with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from eMed? Verify your company email to claim this profile and keep its description, products, and FAQs up to date.
Claim eMed Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention eMed vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →